|
|
||||||||
The Journal of Immunology, Vol 154, Issue 9 4395-4403, Copyright © 1995 by American Association of Immunologists
ARTICLES |
Y Nishimura, A Ishii, Y Kobayashi, Y Yamasaki and S Yonehara
Pharmaceutical Basic Research Laboratories, JT Inc., Yokohama, Japan.
We prepared mAbs specific for the mouse Fas Ag (CD95) and used them to analyze the expression and apoptosis-inducing activity of the Fas Ag on murine immunocytes. Cytofluorometry of mouse bone marrow, thymus, and splenocytes using the mAbs indicated that cells of the T lineage, except for bone marrow cells, expressed Fas Ag on the surface. CD4-CD8- undifferentiated thymocytes expressed low levels of Fas Ag. Immature CD4+CD8+ thymocytes and mature CD4+CD8- and CD4-CD8+ thymocytes were highly positive for Fas Ag. CD4+CD8+ thymocytes were specifically sensitive to the apoptosis-inducing activity of anti-Fas, although CD4- CD8-, CD4+CD8-, and CD4-CD8+ thymocytes were resistant. Spleen T cells were resistant to anti-Fas, whereas they expressed Fas Ag. The superantigen, staphylococcal enterotoxin B (SEB) administered to BALB/c mice, induced clonal expansion and successive clonal deletion of spleen T cells bearing the V beta 8 TCR, which specifically reacts to SEB. Such clonal deletion of V beta 8 T cells was highly suppressed in lpr mice, which have defects in the Fas Ag gene. In SEB-administrated BALB/c mice, expression of Fas Ag was significantly enhanced on V beta 8, but not on V beta 6 T cells, which cannot react to SEB. Moreover, V beta 8 T cells in SEB-primed mice were sensitive to the cell-killing activity of anti-Fas, although V beta 6 T cells were resistant. These findings show that the expression level and apoptosis-inducing activity of Fas Ag on peripheral T cells are directly up-regulated by stimulation through the TCR in vivo.
This article has been cited by other articles:
![]() |
Y. Gong, R. Zhang, J. Zhang, L. Xu, F. Zhang, W. Xu, Y. Wang, Y. Chu, and S. Xiong {alpha}-Dystroglycan is involved in positive selection of thymocytes by participating in immunological synapse formation FASEB J, May 1, 2008; 22(5): 1426 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Abe, K. Kohu, H. Ohmori, K. Hayashi, T. Watanabe, K. Hozumi, T. Sato, S. Habu, and M. Satake Reduction of Runx1 Transcription Factor Activity Up-Regulates Fas and Bim Expression and Enhances the Apoptotic Sensitivity of Double Positive Thymocytes J. Immunol., October 1, 2005; 175(7): 4475 - 4482. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang and Y.-W. He An essential role for c-FLIP in the efficient development of mature T lymphocytes J. Exp. Med., August 1, 2005; 202(3): 395 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Askenasy, E. S. Yolcu, I. Yaniv, and H. Shirwan Induction of tolerance using Fas ligand: a double-edged immunomodulator Blood, February 15, 2005; 105(4): 1396 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Higuchi, T. Orita, K. Katsuya, Y. Yamasaki, K. Akiyama, H. Li, T. Yamamoto, Y. Saito, and M. Nakamura MUC20 Suppresses the Hepatocyte Growth Factor-Induced Grb2-Ras Pathway by Binding to a Multifunctional Docking Site of Met Mol. Cell. Biol., September 1, 2004; 24(17): 7456 - 7468. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yajima, K. Sakamaki, and S. Yonehara Age-related thymic involution is mediated by Fas on thymic epithelial cells Int. Immunol., July 1, 2004; 16(7): 1027 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Boursalian and P. J. Fink Mutation in Fas Ligand Impairs Maturation of Thymocytes Bearing Moderate Affinity T Cell Receptors J. Exp. Med., July 21, 2003; 198(2): 349 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xiao, S. Jodo, S.-s. J. Sung, A. Marshak-Rothstein, and S.-T. Ju A Novel Signaling Mechanism for Soluble CD95 Ligand. SYNERGY WITH ANTI-CD95 MONOCLONAL ANTIBODIES FOR APOPTOSIS AND NF-kappa B NUCLEAR TRANSLOCATION J. Biol. Chem., December 20, 2002; 277(52): 50907 - 50913. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Middlebrook, C. Martina, Y. Chang, R. J. Lukas, and D. DeLuca Effects of Nicotine Exposure on T Cell Development in Fetal Thymus Organ Culture: Arrest of T Cell Maturation J. Immunol., September 15, 2002; 169(6): 2915 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Engel, C. Johns, G. Bain, R. R. Rivera, and C. Murre Early Thymocyte Development Is Regulated by Modulation of E2A Protein Activity J. Exp. Med., September 10, 2001; 194(6): 733 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, W. Jin, H. Tian, P. Sicurello, M. Frank, J. M. Orenstein, and S. M. Wahl Requirement for Transforming Growth Factor {beta}1 in Controlling T Cell Apoptosis J. Exp. Med., August 20, 2001; 194(4): 439 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tu, P.-T. Cheung, and Y.-L. Lau Insulin-Like Growth Factor 1 Promotes Cord Blood T Cell Maturation and Inhibits Its Spontaneous and Phytohemagglutinin-Induced Apoptosis Through Different Mechanisms J. Immunol., August 1, 2000; 165(3): 1331 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshida, T. Higuchi, H. Hagiyama, A. Strasser, K. Nishioka, and T. Tsubata Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice Int. Immunol., April 1, 2000; 12(4): 517 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ichikawa, H. Yoshida-Kato, M. Ohtsuki, J. Ohsumi, J. Yamaguchi, S. Takahashi, Y. Tani, M. Watanabe, A. Shiraishi, K. Nishioka, et al. A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity Int. Immunol., April 1, 2000; 12(4): 555 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, K.-A. Kim, D.-Y. Hwang, T. H. Lee, N. Kayagaki, H. Yagita, and M.-S. Lee Inhibition of Autoimmune Diabetes by Fas Ligand: The Paradox Is Solved J. Immunol., March 15, 2000; 164(6): 2931 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kazama and S. Yonehara Oncogenic K-Ras and Basic Fibroblast Growth Factor Prevent Fas-mediated Apoptosis in Fibroblasts through Activation of Mitogen-activated Protein Kinase J. Cell Biol., February 7, 2000; 148(3): 557 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-P. Min, R. Gorczynski, X.-Y. Huang, M. Kushida, P. Kim, M. Obataki, J. Lei, R. M. Suri, and M. S. Cattral Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival J. Immunol., January 1, 2000; 164(1): 161 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Ludviksson, R. O. Ehrhardt, and W. Strober Role of IL-12 in Intrathymic Negative Selection J. Immunol., October 15, 1999; 163(8): 4349 - 4359. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jenkins, M. Keir, and J. M. McCune Fas Is Expressed Early in Human Thymocyte Development But Does Not Transmit an Apoptotic Signal J. Immunol., August 1, 1999; 163(3): 1195 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Komano, Y. Ikegami, M. Yokoyama, R. Suzuki, S. Yonehara, Y. Yamasaki, and N. Shinohara Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells Int. Immunol., July 1, 1999; 11(7): 1035 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Yeh, S.-C. Hsu, S.-H. Han, and M.-Z. Lai Mitogen-activated Protein Kinase Kinase Antagonized Fas-associated Death Domain Protein-mediated Apoptosis by Induced FLICE-inhibitory Protein Expression J. Exp. Med., November 16, 1998; 188(10): 1795 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fleck, T. Zhou, T. Tatsuta, P. Yang, Z. Wang, and J. D. Mountz Fas/Fas Ligand Signaling During Gestational T Cell Development J. Immunol., April 15, 1998; 160(8): 3766 - 3775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Sohn, K. A. Forbush, N. Nguyen, B. Witthuhn, T. Nosaka, J. N. Ihle, and R. M. Perlmutter Requirement for Jak3 in Mature T Cells: Its Role in Regulation of T Cell Homeostasis J. Immunol., March 1, 1998; 160(5): 2130 - 2138. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suda, H. Hashimoto, M. Tanaka, T. Ochi, and S. Nagata Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing J. Exp. Med., December 15, 1997; 186(12): 2045 - 2050. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Punt, W. Havran, R. Abe, A. Sarin, and A. Singer T Cell Receptor (TCR)-induced Death of Immature CD4+CD8+ Thymocytes by Two Distinct Mechanisms Differing in Their Requirement for CD28 Costimulation: Implications for Negative Selection in the Thymus J. Exp. Med., December 1, 1997; 186(11): 1911 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kishi, S. Saijyo, M. Arai, S. Karasawa, S. Ueda, M. Kannagi, Y. Iwakura, M. Fujii, and S. Yonehara Resistance to Fas-mediated Apoptosis of Peripheral T Cells in Human T Lymphocyte Virus Type I (HTLV-I) Transgenic Mice with Autoimmune Arthropathy J. Exp. Med., July 7, 1997; 186(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Biancone, A. D. Martino, V. Orlandi, P. G. Conaldi, A. Toniolo, and G. Camussi Development of Inflammatory Angiogenesis by Local Stimulation of Fas In Vivo J. Exp. Med., July 7, 1997; 186(1): 147 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kiener, P. M. Davis, G. C. Starling, C. Mehlin, S. J. Klebanoff, J. A. Ledbetter, and W. C. Liles Differential Induction of Apoptosis by Fas-Fas Ligand Interactions in Human Monocytes and Macrophages J. Exp. Med., April 21, 1997; 185(8): 1511 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kayagaki, N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita Polymorphism of murine Fas ligand that affects the biological activity PNAS, April 15, 1997; 94(8): 3914 - 3919. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Baker, R. L. Riley, E. R. Podack, and R. B. Levy Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function PNAS, February 18, 1997; 94(4): 1366 - 1371. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |